Follow
Huihui Mu
Huihui Mu
Boston Children's Hospital, Harvard Medical School
Verified email at childrens.harvard.edu
Title
Cited by
Cited by
Year
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
VS Raj, H Mou, SL Smits, DHW Dekkers, MA Müller, R Dijkman, D Muth, ...
Nature 495 (7440), 251-254, 2013
23862013
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
L Zhang, CB Jackson, H Mou, A Ojha, H Peng, BD Quinlan, ...
Nature communications 11 (1), 6013, 2020
10952020
The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity
L Zhang, CB Jackson, H Mou, A Ojha, ES Rangarajan, T Izard, M Farzan, ...
BioRxiv, 2020
5852020
The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing …
H Mou, VS Raj, FJM Van Kuppeveld, PJM Rottier, BL Haagmans, ...
Journal of virology 87 (16), 9379-9383, 2013
2482013
Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2
T Ou, H Mou, L Zhang, A Ojha, H Choe, M Farzan
PLoS pathogens 17 (1), e1009212, 2021
2202021
The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement
BD Quinlan, H Mou, L Zhang, Y Guo, W He, A Ojha, MS Parcells, G Luo, ...
Biorxiv, 2020.04. 10.036418, 2020
1482020
Specific serology for emerging human coronaviruses by protein microarray
C Reusken, H Mou, GJ Godeke, L van der Hoek, B Meyer, MA Müller, ...
Eurosurveillance 18 (14), 2013
1292013
Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody
K Ohnuma, BL Haagmans, R Hatano, VS Raj, H Mou, S Iwata, NH Dang, ...
Journal of virology 87 (24), 13892-13899, 2013
1112013
A reversible RNA on-switch that controls gene expression of AAV-delivered therapeutics in vivo
G Zhong, H Wang, W He, Y Li, H Mou, ZJ Tickner, MH Tran, T Ou, Y Yin, ...
Nature biotechnology 38 (2), 169-175, 2020
752020
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat Commun 11: 6013
L Zhang, CB Jackson, H Mou, A Ojha, H Peng, BD Quinlan, ...
502020
The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv 2020
L Zhang, CB Jackson, H Mou, A Ojha, ES Rangarajan, T Izard, M Farzan, ...
Google Scholar, 0
47
Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2
H Mou, BD Quinlan, H Peng, G Liu, Y Guo, S Peng, L Zhang, ...
PLoS pathogens 17 (4), e1009501, 2021
342021
The receptor binding domain of the new MERS coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies
H Mou, VS Raj, FJM van Kuppeveld, PJM Rottier, BL Haagmans, ...
Coronavirus spike-receptor interactions 87 (16), 65, 2015
312015
Conditional Regulation of Gene Expression by Ligand-Induced Occlusion of a MicroRNA Target Sequence
FM Mou H, Zhong G, Gardner MR, Wang H, Wang YW, Cheng D
Molecular Therapy, 2018
302018
Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2
H Mou, BD Quinlan, H Peng, Y Guo, S Peng, L Zhang, ME Davis-Gardner, ...
BioRxiv, 2020
252020
A more efficient CRISPR-Cas12a variant derived from Lachnospiraceae bacterium MA2020
MH Tran, H Park, CL Nobles, P Karunadharma, L Pan, G Zhong, H Wang, ...
Molecular Therapy-Nucleic Acids 24, 40-53, 2021
232021
Identification of potent small molecule inhibitors of SARS-CoV-2 entry
S Mediouni, H Mou, Y Otsuka, JA Jablonski, RS Adcock, L Batra, ...
Slas Discovery 27 (1), 8-19, 2022
222022
Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells
C Riou, G Schäfer, E Du Bruyn, RT Goliath, C Stek, H Mou, D Hung, ...
European Respiratory Journal 59 (1), 2022
202022
An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines
Y Guo, W He, H Mou, L Zhang, J Chang, S Peng, A Ojha, R Tavora, ...
Mbio 12 (3), 10.1128/mbio. 00930-21, 2021
192021
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens
ET Crooks, F Almanza, A D’addabbo, E Duggan, J Zhang, K Wagh, ...
PLoS pathogens 17 (10), e1009807, 2021
122021
The system can't perform the operation now. Try again later.
Articles 1–20